CAH stock performance in healthcare sector

What happened: Cardinal Health (CAH), a major healthcare services and products company, has seen mixed sentiment from analysts and investors. Jim Cramer recently praised CAH as a "stalwart" and suggested it could trade higher, while the Jim Cramer's Charitable Trust trimmed its CAH position into strength, selling 50 shares at around $235. CAH's market cap stands at $53.2 billion.

Market impact: CAH's performance has implications for the broader healthcare sector. As a significant player in pharmaceutical distribution and healthcare product manufacturing, CAH's stock movements can influence investor sentiment towards the sector. The healthcare sector has been the best performer this week, with CAH contributing to this trend.

What to watch next: Upcoming catalysts include CAH's next earnings report, scheduled for late August, which will provide insights into the company's financial health and growth prospects. Additionally, investors should monitor any regulatory developments affecting the healthcare industry, as these can impact CAH's operations and stock performance. Lastly, technical levels around $235 will be crucial, as this is where the Charitable Trust recently sold its shares.